Abstract
In this issue of Blood, Haddad and colleagues on behalf of the Primary Immune Deficiency Treatment Consortium report retrospective outcome data on hematopoietic stem cell transplantation (HSCT) for 662 patients with severe combined immunodeficiency (SCID) treated between 1982 and 2012 in 33 North American institutions.1
Cite
CITATION STYLE
APA
Gennery, A. R. (2018, October 25). Predicting the future with TRECs. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2018-09-873638
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free